KVAC:NASDAQKeen Vision Acquisition Corporation Analysis
Data as of 2026-04-13 - not real-time
$12.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Keen Vision Acquisition trades at $12, just above its 20‑day SMA of 11.99 and marginally above the 50‑day SMA of 11.92, suggesting a modest bullish bias. The RSI sits at 60, indicating continued upward momentum but no overbought condition. However, the MACD histogram is negative and the signal line is labeled bearish, warning of potential short‑term weakness. Price is hugging the $12 resistance while the nearest support sits at $11.85, a narrow trading range that could be breached on a catalyst. Volume has been decreasing, and the beta is effectively flat at –0.03, implying little market‑wide correlation but also limited price support. Volatility over the past 30 days is about 5%, modest for a SPAC with such limited liquidity.
Fundamentally, KVAC reports zero revenue, negative book value per share, and a PE ratio of 63 versus an industry average of 17, flagging severe overvaluation. The price‑to‑book metric is deeply negative at –15.8, reflecting a balance sheet that is more debt‑laden than asset‑rich. Cash on hand is modest at $11,206 thousand against $3,983,902 thousand of debt, and there is no dividend to speak of. The Fear & Greed Index reads “Extreme Greed,” which may be inflating price despite the lack of operating performance. Given the SPAC structure, the absence of earnings, and the high valuation multiples, the stock carries elevated risk with limited upside unless a compelling merger materializes.
Fundamentally, KVAC reports zero revenue, negative book value per share, and a PE ratio of 63 versus an industry average of 17, flagging severe overvaluation. The price‑to‑book metric is deeply negative at –15.8, reflecting a balance sheet that is more debt‑laden than asset‑rich. Cash on hand is modest at $11,206 thousand against $3,983,902 thousand of debt, and there is no dividend to speak of. The Fear & Greed Index reads “Extreme Greed,” which may be inflating price despite the lack of operating performance. Given the SPAC structure, the absence of earnings, and the high valuation multiples, the stock carries elevated risk with limited upside unless a compelling merger materializes.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD histogram
- decreasing trading volume
- price positioned near resistance
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- PE far above industry average
- negative book value and high debt
- absence of revenue or earnings
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential upside from a successful business combination
- available cash cushion
- persistent sector and liquidity uncertainties
Key Metrics & Analysis
Financial Health
P/E Ratio63.2
P/B Ratio-15.8
Op. Cash Flow$-784137
Industry P/E17.4
Technical Analysis
TrendBullish
RSI60.1
Support$11.85
Resistance$12.00
MA 20$11.99
MA 50$11.92
MA 200$11.69
MACDBearish
VolumeDecreasing
Fear & Greed Index87.29
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-0.03
Volatility5.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.